However, HNSCC could be a very attractive target for the application of DNA-PK inhibitors as p53 is often mutated or deregulated by HPV and HR-deficient cells are addicted to NHEJ, so synthetic lethality can be induced [19, 26]. This evidence concerns the gene PRKDC and head and neck squamous cell carcinoma.